Bone Biologics Future Growth
Future criteria checks 0/6
Bone Biologics's earnings are forecast to decline at 30.9% per annum. EPS is expected to grow by 4.9% per annum.
Key information
-30.9%
Earnings growth rate
4.9%
EPS growth rate
| Biotechs earnings growth | 19.8% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 15 Nov 2023 |
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | N/A | -14 | N/A | N/A | 1 |
| 12/31/2024 | N/A | -13 | N/A | N/A | 1 |
| 12/31/2023 | N/A | N/A | N/A | N/A | 1 |
| 9/30/2023 | N/A | -7 | -9 | -9 | N/A |
| 6/30/2023 | N/A | -6 | -7 | -7 | N/A |
| 3/31/2023 | N/A | -5 | -4 | -4 | N/A |
| 12/31/2022 | N/A | -1 | -4 | -4 | N/A |
| 9/30/2022 | N/A | -3 | -2 | -2 | N/A |
| 6/30/2022 | N/A | -2 | -2 | -2 | N/A |
| 3/31/2022 | N/A | -2 | -2 | -2 | N/A |
| 12/31/2021 | N/A | -2 | -1 | -1 | N/A |
| 9/30/2021 | N/A | -2 | -1 | -1 | N/A |
| 6/30/2021 | N/A | -2 | -1 | -1 | N/A |
| 3/31/2021 | N/A | -2 | 0 | 0 | N/A |
| 12/31/2020 | N/A | -2 | 0 | 0 | N/A |
| 9/30/2020 | N/A | -2 | -1 | -1 | N/A |
| 6/30/2020 | N/A | -2 | -1 | -1 | N/A |
| 3/31/2020 | N/A | -3 | -2 | -2 | N/A |
| 12/31/2019 | N/A | -3 | -3 | -3 | N/A |
| 9/30/2019 | N/A | -4 | -4 | -4 | N/A |
| 6/30/2019 | N/A | -4 | -5 | -5 | N/A |
| 3/31/2019 | N/A | -4 | -4 | -4 | N/A |
| 12/31/2018 | N/A | -4 | -4 | -4 | N/A |
| 9/30/2018 | N/A | -6 | -4 | -4 | N/A |
| 6/30/2018 | N/A | -8 | -3 | -3 | N/A |
| 3/31/2018 | N/A | -6 | -3 | -3 | N/A |
| 12/31/2017 | N/A | -7 | -3 | -3 | N/A |
| 9/30/2017 | N/A | -14 | -4 | -4 | N/A |
| 6/30/2017 | N/A | -16 | N/A | -5 | N/A |
| 3/31/2017 | N/A | -22 | N/A | -6 | N/A |
| 12/31/2016 | N/A | -26 | N/A | -7 | N/A |
| 9/30/2016 | N/A | -24 | N/A | -7 | N/A |
| 6/30/2016 | N/A | -23 | N/A | -7 | N/A |
| 3/31/2016 | N/A | -19 | N/A | -6 | N/A |
| 12/31/2015 | N/A | -14 | N/A | -4 | N/A |
| 9/30/2015 | N/A | -7 | N/A | -4 | N/A |
| 6/30/2015 | N/A | -6 | N/A | -4 | N/A |
| 3/31/2015 | N/A | -6 | N/A | -3 | N/A |
| 12/31/2014 | N/A | -4 | N/A | -3 | N/A |
| 9/30/2014 | N/A | -4 | N/A | -1 | N/A |
| 6/30/2014 | N/A | -1 | N/A | 0 | N/A |
| 3/31/2014 | N/A | -1 | N/A | 0 | N/A |
| 12/31/2013 | N/A | -1 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BBLG is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: BBLG is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: BBLG is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if BBLG's revenue is forecast to grow faster than the US market.
High Growth Revenue: BBLG is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BBLG's Return on Equity is forecast to be high in 3 years time